Annual Drug Patent Expirations for BOSULIF
Bosulif is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for BOSULIF.
This drug has forty-one patent family members in twenty-nine countries.
The generic ingredient in BOSULIF is bosutinib monohydrate. Two suppliers are listed for this compound. Additional details are available on the bosutinib monohydrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
